Cargando…

Clinical sensitivity of antibodies against cyclic citrulinated peptide in patients with rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Bozic, B, Cucnik, S, Ambrozic, A, Lestan, B, Kos-Golja, M, Rozman B, B, Kveder T, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273238/ http://dx.doi.org/10.1186/ar172

Ejemplares similares

Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus
por: Ambrozic, A, et al.
Publicado: (2004)

Prothrombin fragment F1+2 in patients with antiphospholipid antibodies
por: Ambrozic, A, et al.
Publicado: (2004)

Antibodies against 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor
por: Zigon, P, et al.
Publicado: (2004)

High-affinity antibodies against β(2)-glycoprotein I
por: Cucnik, S, et al.
Publicado: (2003)

Paratope diversity of anti-prothrombin antibodies
por: Cucnik, S, et al.
Publicado: (2003)

Do IgA antiphospholipid antibodies have any clinical importance?
por: Gaspersic, GN, et al.
Publicado: (2002)

Concomitant appearance of anti-cardiolipin, anti-β(2)-glycoprotein I, anti-prothrombin and anti-annexin V antibodies
por: Cucnik, S, et al.
Publicado: (2004)

Rational Laboratory Diagnostics of Antiphospholipid Antibodies: Anti-Cardiolipin, Anti-β2-Glycoprotein I, Anti-Prothrombin and Anti-Annexin V Antibodies
por: Borut, Bozic, et al.
Publicado: (2010)

Cerebrovascular insult and antiphospholipid antibodies in young adults
por: Cucnik, S, et al.
Publicado: (2002)

Isolation of beta2GPI by perchloric acid yields three proteins having different antigenic properties
por: Cucnik, S, et al.
Publicado: (2001)

Detection of Antiphosphatidylserine/Prothrombin Antibodies and Their Potential Diagnostic Value
por: Žigon, Polona, et al.
Publicado: (2013)

Heterogeneous behaviour of anti-beta(2)-glycoprotein I antibodies on different "high binding" microtiter plates
por: Ambrozic, A, et al.
Publicado: (2001)

Improving an anti-beta(2) GPI ELISA by reducing the influence of a blocking agent
por: Ambrozic, A, et al.
Publicado: (2001)

The role of antibodies to mutated citrulinated vimentin (anti-MCV) in juvenile idiopathic arthritis patients
por: Lamot, L, et al.
Publicado: (2008)

The association of HLA-DR/DQ coding and QBP promoter allelic polymorphism with antiphospholipid antibody response in SLE
por: Logar, D, et al.
Publicado: (2002)

Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
por: Žigon, Polona, et al.
Publicado: (2015)

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
por: van Damme, N, et al.
Publicado: (2002)

Investigation of the epitopes of human profilaggrin derived peptide targeted by antibodies of patient with rheumatoid arthritis
por: Brozik, M, et al.
Publicado: (2001)

Ability of second-generation anti-cyclic citrullinated peptide (CCP) to predict rheumatoid arthritis in patients with early arthritis
por: Saraux, A, et al.
Publicado: (2003)

The significance of antibodies to cyclic citrullinated peptide, antikeratin antibodies, anti-perinuclear factor, rheumatoid factor isotypes and HLA shared epitope in prediction of erosive disease in early rheumatoid arthritis patients
por: Vencovsky, J, et al.
Publicado: (2001)

Comparison and evaluation of different methodologies and tests for detection of anti-dsDNA antibodies on 889 Slovenian patients’ and blood donors’ sera
por: Žigon, Polona, et al.
Publicado: (2011)

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2004)

Investigation of the reactivity patterns of antifilaggrin antibodies in sera and synovial fluids from patients with rheumatoid arthritis using citrullinated synthetic peptides
por: Brózik, M, et al.
Publicado: (2003)

Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
por: El-Banna, Hassan, et al.
Publicado: (2014)

Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
por: Vignesh, Ammapati Paul Pandian, et al.
Publicado: (2015)

Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients
por: Mohamad, Wan Majdiah Wan, et al.
Publicado: (2018)

Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis
por: Li, Chun, et al.
Publicado: (2019)

Anti-BIP antibodies in rheumatoid arthritis
por: Panayi, GS, et al.
Publicado: (2003)

Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
por: Mewar, Devesh, et al.
Publicado: (2006)

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
por: Alexiou, Ioannis, et al.
Publicado: (2007)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
por: Bo, Li, et al.
Publicado: (2008)

The influence of anti-cyclic citrullinated peptide on anticentromere antibody-positive rheumatoid arthritis patients
por: Jearn, La-He, et al.
Publicado: (2010)

Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis
por: Abdul Wahab, Asrul, et al.
Publicado: (2013)

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
por: Shibahara, Tomoya, et al.
Publicado: (2016)

Diagnostic Performances of Anti-Cyclic Citrullinated Peptides Antibody and Antifilaggrin Antibody in Korean Patients with Rheumatoid Arthritis
por: Choi, Suk Woo, et al.
Publicado: (2005)

Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients
por: Sulaiman, Farah Nadiah, et al.
Publicado: (2019)

Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic
por: Singh, Prabhakar, et al.
Publicado: (2020)

The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis
por: Heidari, Behzad, et al.
Publicado: (2009)

Optimization of Unnicked β2-Glycoprotein I and High Avidity Anti-β2-Glycoprotein I Antibodies Isolation
por: Artenjak, Andrej, et al.
Publicado: (2014)

Anti-Ro/SSA antibodies in rheumatoid arthritis (RA)
por: Franceschini, F, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_78k0mjg9b4trk8n74qj7slcdr4